Microbiota-associated metabolic reprograming influenced clinical outcome in the randomized dendritic cell-based clinical trial in stage III melanoma

Published: 19 September 2023| Version 1 | DOI: 10.17632/nzb653783h.1
Déborah Suissa, Carolina ALVES COSTA SiILVA, Lisa Derosa, Damien Drubay, Jolanda M. de Vries, Kalijn Bol, Roxanne Birebent, Marine Fidelle, sylvere durand, Cisse Sow, Safae Terrisse, Bertrand Routy, Guido Kroemer, Nicola Segata, Laurence Zitvogel, Gianmarco Piccinno, Fanny Aprahamian, Paolo Manghi, alexander eggermont, Mélanie Bourgin, Gerty Schreibelt, Federica Pinto, Federica Armanini, Francesco Asnicar

Embargo: 18 December 2023, 12:00 AM UTC

This dataset will be made public in 11 days

What does under embargo mean?

When publishing a dataset, a user may choose to defer the date at which the data becomes available (for example, so that it is available at the same time as an associated article). This means that the description and files of that dataset are not publicly available until the embargo date is reached. Meanwhile, some other information about the dataset - such as the contributors, title, citation and associated articles become available immediately, prior to the embargo.

Download calendar event